USD 0.05
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 505 Thousand USD | -96.07% |
2022 | 12.83 Million USD | -12.37% |
2021 | 14.65 Million USD | 384.65% |
2020 | 3.02 Million USD | -26.07% |
2019 | 4.08 Million USD | 971.95% |
2018 | 381.45 Thousand USD | 31.06% |
2017 | 291.06 Thousand USD | 121.52% |
2016 | 131.39 Thousand USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 235 Thousand USD | -53.47% |
2024 Q2 | 135 Thousand USD | -100.0% |
2023 FY | 505 Thousand USD | -96.07% |
2023 Q3 | 10.88 Million USD | -3.94% |
2023 Q2 | 11.33 Million USD | 0.68% |
2023 Q1 | 11.25 Million USD | -12.33% |
2023 Q4 | 505 Thousand USD | -95.36% |
2022 Q3 | 13.73 Million USD | 0.56% |
2022 Q4 | 12.83 Million USD | -6.5% |
2022 FY | 12.83 Million USD | -12.37% |
2022 Q1 | 13.55 Million USD | -7.47% |
2022 Q2 | 13.65 Million USD | 0.72% |
2021 Q3 | 11.2 Million USD | 1.49% |
2021 Q2 | 11.03 Million USD | 129.94% |
2021 FY | 14.65 Million USD | 384.65% |
2021 Q4 | 14.65 Million USD | 30.8% |
2021 Q1 | 4.8 Million USD | 58.78% |
2020 Q3 | 3.65 Million USD | -8.82% |
2020 Q1 | 4.54 Million USD | 11.2% |
2020 FY | 3.02 Million USD | -26.07% |
2020 Q2 | 4 Million USD | -11.96% |
2020 Q4 | 3.02 Million USD | -17.18% |
2019 FY | 4.08 Million USD | 971.95% |
2019 Q2 | 1.62 Million USD | -9.2% |
2019 Q4 | 4.08 Million USD | 166.02% |
2019 Q3 | 1.53 Million USD | -5.36% |
2019 Q1 | 1.78 Million USD | 368.93% |
2018 Q2 | 317.67 Thousand USD | -11.44% |
2018 FY | 381.45 Thousand USD | 31.06% |
2018 Q4 | 381.45 Thousand USD | 21.09% |
2018 Q3 | 315.02 Thousand USD | -0.84% |
2018 Q1 | 358.72 Thousand USD | 23.25% |
2017 Q3 | 212.55 Thousand USD | 17.94% |
2017 Q4 | 291.06 Thousand USD | 36.94% |
2017 Q2 | 180.21 Thousand USD | -8.97% |
2017 Q1 | 197.96 Thousand USD | 50.66% |
2017 FY | 291.06 Thousand USD | 121.52% |
2016 Q4 | 131.39 Thousand USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 FY | 131.39 Thousand USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 1.34 Billion USD | 99.962% |
Addus HomeCare Corporation | 124.13 Million USD | 99.593% |
AirSculpt Technologies, Inc. | 69.5 Million USD | 99.273% |
Amedisys, Inc. | 346.76 Million USD | 99.854% |
American Oncology Network, Inc. | 120.44 Million USD | 99.581% |
Astrana Health, Inc. | 296.26 Million USD | 99.83% |
Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | 99.96% |
IMAC Holdings, Inc. | - USD | -Infinity% |
biote Corp. | 106.63 Million USD | 99.526% |
Cryo-Cell International, Inc. | 9.28 Million USD | 94.559% |
Cross Country Healthcare, Inc. | 2.66 Million USD | 81.036% |
COMPASS Pathways plc | 28.75 Million USD | 98.244% |
DocGo Inc. | 15.16 Million USD | 96.669% |
The Ensign Group, Inc. | 1.78 Billion USD | 99.972% |
Healthcare Services Group, Inc. | 11.23 Million USD | 95.505% |
InnovAge Holding Corp. | 100.49 Million USD | 99.497% |
The Joint Corp. | 2 Million USD | 74.75% |
LifeStance Health Group, Inc. | 280.28 Million USD | 99.82% |
Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -32.393% |
ModivCare Inc. | 983.75 Million USD | 99.949% |
NewGenIvf Group Limited | 118.97 Thousand USD | -324.445% |
Novo Integrated Sciences, Inc. | 1.75 Million USD | 71.284% |
Option Care Health, Inc. | 1.05 Billion USD | 99.952% |
P3 Health Partners Inc. | 108.31 Million USD | 99.534% |
P3 Health Partners Inc. | 108.31 Million USD | 99.534% |
The Pennant Group, Inc. | 312.51 Million USD | 99.838% |
Surgery Partners, Inc. | 2.03 Billion USD | 99.975% |
Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
Talkspace, Inc. | - USD | -Infinity% |
Talkspace, Inc. | - USD | -Infinity% |
The Oncology Institute, Inc. | 86.82 Million USD | 99.418% |
The Oncology Institute, Inc. | 86.82 Million USD | 99.418% |